cisplatin toxicity
Showing 1 - 25 of 8,997
Drug Toxicity Trial in Rawalpindi (N-Acetylcysteine, Chemotherapy)
Active, not recruiting
- Drug Toxicity
-
Rawalpindi, Punjab, PakistanMedical Oncology department, Fauji Foundation Hospital
Aug 25, 2023
Genetic and Epigenetic Factors on Clinical Response and Toxicity
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Cisplatin injection
-
Cairo, EgyptAin Shams University
Feb 16, 2023
Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed
Completed
- Ovarian Neoplasm
- +4 more
- (no location specified)
Aug 22, 2022
Peritoneum; Carcinomatosis, Peritoneal Tumors, Peritoneal Metastases Trial in Odense (PIPAC)
Completed
- Peritoneum; Carcinomatosis
- +6 more
-
Odense, DenmarkDepartment of Surgery, Odense University Hospital
Oct 5, 2022
Cancer Therapy-related Cardiovascular Toxicity Trial in Beijing (Bifidobacterium Bifidum Oral Capsule, Cisplatin, Carboplatin)
Not yet recruiting
- Cancer Therapy-related Cardiovascular Toxicity
- Bifidobacterium Bifidum Oral Capsule
- +4 more
-
Beijing, ChinaPeking University Third Hospital
Feb 15, 2023
Cisplatin Induced Kidney Toxicity
Recruiting
- Acute Kidney Injury
- Cancer
- Questionnaire, sampling of blood, urine and saliva
-
London, ONT, CanadaLondon Health Sciences Centre
Jun 30, 2021
Cervical Cancer, Chemo Effect, Programmed Cell Death 1 Receptor / Antagonists & Inhibitors Trial (Sindilimab +paclitaxel+
Not yet recruiting
- Cervical Cancer
- +3 more
- Sindilimab +paclitaxel+ cisplantin
- (no location specified)
Mar 14, 2021
Cancer Treatment
Recruiting
- Toxicity Due to Chemotherapy
- +2 more
- Anthracyclines
- +3 more
-
Groningen, NetherlandsUniversity Medical Center Groningen
Feb 1, 2021
Esophageal Cancer Trial in ZhengZhou (Lobaplatin, Cisplatin)
Completed
- Esophageal Cancer
-
ZhengZhou, Henan, ChinaHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Aug 26, 2020
Mesothelioma Trial in United States (procedure, drug, radiation)
Active, not recruiting
- Mesothelioma
- Pleurectomy/Decortication
- +2 more
-
Tampa, Florida
- +12 more
May 9, 2022
Chemo;Advanced Gastric Cancer;Cisplatin;Disulfiram Trial in Hangzhou (disulfiram and cisplatin, cisplatin)
Not yet recruiting
- Chemotherapy；Advanced Gastric Cancer；Cisplatin；Disulfiram
- disulfiram and cisplatin
- cisplatin
-
Hangzhou, Zhejiang, ChinaHangzhou first people's Hospital
Dec 26, 2022
Ovarian Cancer, Malignant Tumor of Uterus Trial in New York (Sacituzumab, Cisplatin)
Not yet recruiting
- Ovarian Cancer
- Malignant Neoplasm of Uterus
-
New York, New YorkIcahn School of Medicine at Mount Sinai Division of Hematology a
Sep 14, 2023
Locally Advanced Unresectable Esophageal Squamous Carcinoma Trial in Jinan, Tianjin (Docetaxel for Injection (Albumin-bound),
Not yet recruiting
- Locally Advanced Unresectable Esophageal Squamous Carcinoma
- Docetaxel for Injection (Albumin-bound)
- +4 more
-
Jinan, Shandong, China
- +1 more
Nov 16, 2023
Head Neck Cancer Trial in Winston-Salem (biological, drug, procedure, radiation)
Completed
- Head and Neck Cancer
- cetuximab
- +8 more
-
Winston-Salem, North CarolinaWake Forest University Comprehensive Cancer Center
Mar 30, 2020
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Trial
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Biospecimen Collection
- +9 more
- (no location specified)
Oct 10, 2023
Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (gemcitabine and cisplatin,
Recruiting
- Nasopharyngeal Carcinoma
- +3 more
- gemcitabine and cisplatin
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 4, 2022
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in United States (Nivolumab, Cisplatin, Cetuximab)
Completed
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Nivolumab
- +3 more
-
Palo Alto, California
- +10 more
Nov 22, 2022
Ovarian Cancer, Hyperthermic Intraperitoneal Chemo, Paclitaxel Trial in Guangzhou (Hyperthermic Intraperitoneal Paclitaxel
Recruiting
- Ovarian Cancer
- +2 more
- Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin
-
Guangzhou, Other (Non U.s.), ChinaSun Yat-sen Memorial Hospital
Nov 11, 2022
Intrahepatic Cholangiocarcinoma Trial (procedure, drug, biological)
Not yet recruiting
- Intrahepatic Cholangiocarcinoma
- Biopsy
- +7 more
- (no location specified)
Sep 21, 2023
Nasopharyngeal Carcinoma Trial in Guangzhou, Zhongshan, Nanning (IMRT and concurrent cisplatin, gemcitabine and cisplatin
Not yet recruiting
- Nasopharyngeal Carcinoma
- IMRT and concurrent cisplatin
- gemcitabine and cisplatin (Induction chemotherapy)
-
Guangzhou, Guangdong, China
- +3 more
Jul 30, 2023
Kidney Diseases Trial in Toulouse (Urinary and blood sample for Cystatine dosage)
Completed
- Kidney Diseases
- Urinary and blood sample for Cystatine dosage
-
Toulouse, FranceCHU Toulouse
Apr 22, 2022
Advanced Biliary Tract Cancer Trial (anlotinib+TQB2450+nab-paclitaxel+cisplatin)
Not yet recruiting
- Advanced Biliary Tract Cancer
- (no location specified)
Apr 2, 2023
Local Advanced High Risk Nasopharyngeal Carcinoma Trial in Guangzhou (IMRT combine with cisplatin concurrent chemo, IMRT combine
Active, not recruiting
- Local Advanced High Risk Nasopharyngeal Carcinoma
- IMRT combine with cisplatin concurrent chemotherapy
- IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy
-
Guangzhou, Guangdong, ChinaCancer Center, Sun Yat-sen University
Mar 13, 2022
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,
Not yet recruiting
- Pancreatic Acinar Cell Carcinoma
- +6 more
- Nab paclitaxel
- +5 more
- (no location specified)
Oct 30, 2023